Cite
MLA Citation
I. Mcinnes et al.. “OP0227 SECUKINUMAB VERSUS ADALIMUMAB HEAD-TO-HEAD COMPARISON IN BIOLOGIC-NAÏVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS THROUGH 52-WEEKS (EXCEED): A RANDOMISED, DOUBLE-BLIND, PHASE-3B STUDY.” Annals of the rheumatic diseases, vol. 79, n.d., pp. 142–143. http://access.bl.uk/ark:/81055/vdc_100144718674.0x000043